The UK Medicines and Healthcare products Regulatory Agency (MHRA) is issuing a patient alert card for men prescribed finasteride. The card is intended to raise awareness of the drug’s psychiatric side effects and sexual dysfunction, including the possibility that sexual dysfunction may continue after treatment is stopped.
Actualizaciones regulatorias25 ago 2026•1 min de lectura
MHRA Introduces Patient Alert Card for Finasteride Users
A new patient alert card warns men on finasteride of psychiatric side effects and persistent sexual dysfunction.
Recopilado por el equipo de PharmaCountry · Fuente: MHRA
Calificaciones
(0)
(0)
(0)
(0)
(0)
Más artículos
Ver todos los artículosInvestigación e Informes
Global Finished Dosage Manufacturing Landscape 2026
5 oct 2026
Actualizaciones regulatoriasKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28 sept 2026
AnálisisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28 sept 2026
Deja tu valoración